Im vergangenen Jahr erzielte Smith & Nephew PLC für sein leistungsstärkstes Segment, Sports Medicine Joint Repair, Einnahmen von 1.07B USD. Die Region United States of America leistete den größten Beitrag mit 3.31B USD im letzten Jahr. Im letzten Quartal berichtete Smith & Nephew PLC über Einnahmen in Höhe von 300.00M USD für den Zeitraum bis zum 2026-06-27, die aus dem leistungsstärksten Segment, Advanced Wound Care, stammten. United States of America trug mit 816.00M USD den höchsten Umsatz bei.

Nach Geschäftsbereich

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

Sports Medicine Joint Repair

Knee Implants

Advanced Wound Care

Trauma & Extremities

Arthroscopic Enabling Technologies

Hip Implants

Advanced Wound Bioactives

Advanced Wound Devices

ENT (Ear, Nose and Throat)

Other Surgical Businesses

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

Sports Medicine Joint Repair

1.07B(17.31%)

982.00M(16.90%)

945.00M(17.03%)

870.00M(16.68%)

839.00M(16.10%)

710.00M(15.57%)

794.00M(15.45%)

697.00M(14.21%)

Knee Implants

1.01B(16.40%)

947.00M(16.30%)

940.00M(16.94%)

899.00M(17.24%)

876.00M(16.81%)

822.00M(18.03%)

1.04B(20.28%)

1.02B(20.74%)

Advanced Wound Care

766.00M(12.43%)

735.00M(12.65%)

725.00M(13.07%)

712.00M(13.65%)

731.00M(14.03%)

647.00M(14.19%)

714.00M(13.90%)

740.00M(15.09%)

Trauma & Extremities

649.00M(10.53%)

608.00M(10.46%)

564.00M(10.16%)

543.00M(10.41%)

576.00M(11.05%)

460.00M(10.09%)

488.00M(9.50%)

493.00M(10.05%)

Arthroscopic Enabling Technologies

647.00M(10.50%)

632.00M(10.88%)

588.00M(10.60%)

567.00M(10.87%)

590.00M(11.32%)

517.00M(11.34%)

591.00M(11.50%)

600.00M(12.23%)

Hip Implants

641.00M(10.40%)

619.00M(10.65%)

599.00M(10.79%)

584.00M(11.20%)

612.00M(11.74%)

567.00M(12.43%)

613.00M(11.93%)

613.00M(12.50%)

Advanced Wound Bioactives

621.00M(10.07%)

581.00M(10.00%)

553.00M(9.97%)

520.00M(9.97%)

496.00M(9.52%)

431.00M(9.45%)

424.00M(8.25%)

320.00M(6.53%)

Advanced Wound Devices

406.00M(6.59%)

365.00M(6.28%)

328.00M(5.91%)

280.00M(5.37%)

269.00M(5.16%)

232.00M(5.09%)

242.00M(4.71%)

215.00M(4.38%)

ENT (Ear, Nose and Throat)

220.00M(3.57%)

210.00M(3.61%)

196.00M(3.53%)

153.00M(2.93%)

131.00M(2.51%)

106.00M(2.32%)

151.00M(2.94%)

--(--)

Other Surgical Businesses

136.00M(2.21%)

131.00M(2.25%)

111.00M(2.00%)

87.00M(1.67%)

92.00M(1.77%)

68.00M(1.49%)

79.00M(1.54%)

209.00M(4.26%)

Nach Region

Umsatz

Anteil

Jährlich

Jährlich

Vierteljährlich

United States of America

Other Established Markets

Emerging &internatiuonal market

United Kingdom

China

Other

Established Markets

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

FY2011

United States of America

3.31B(53.63%)

3.12B(53.75%)

2.98B(53.69%)

2.76B(53.00%)

2.66B(51.00%)

2.34B(51.29%)

2.55B(49.65%)

2.35B(48.00%)

2.33B(48.94%)

2.30B(49.24%)

2.22B(47.84%)

2.01B(43.58%)

1.86B(42.79%)

1.65B(39.91%)

1.76B(41.12%)

Other Established Markets

1.48B(24.03%)

1.27B(21.88%)

1.14B(20.45%)

999.00M(19.16%)

1.10B(21.05%)

966.00M(21.18%)

1.08B(21.08%)

1.48B(30.22%)

--(--)

1.71B(41.24%)

1.77B(41.43%)

Emerging &internatiuonal market

1.00B(16.27%)

980.00M(16.87%)

959.00M(17.28%)

947.00M(18.16%)

916.00M(17.57%)

771.00M(16.91%)

957.00M(18.63%)

857.00M(17.48%)

--(--)

677.00M(14.66%)

563.00M(12.94%)

483.00M(11.68%)

454.00M(10.63%)

United Kingdom

246.00M(3.99%)

226.00M(3.89%)

201.00M(3.62%)

186.00M(3.57%)

189.00M(3.63%)

166.00M(3.64%)

211.00M(4.11%)

211.00M(4.30%)

244.00M(5.12%)

266.00M(5.70%)

301.00M(6.50%)

299.00M(6.48%)

293.00M(6.73%)

297.00M(7.18%)

291.00M(6.81%)

China

128.00M(2.08%)

210.00M(3.61%)

275.00M(4.96%)

319.00M(6.12%)

352.00M(6.75%)

318.00M(6.97%)

336.00M(6.54%)

--(--)

Other

--(--)

2.19B(45.94%)

2.10B(45.06%)

2.12B(45.66%)

--(--)

Established Markets

--(--)

1.63B(35.28%)

1.63B(37.53%)

--(--)